સુરક્ષા ડૈગનોસ્ટિક લિમિટેડ Ipo

Initial public offering of up to 19,189,330 equity shares of face value of Rs. 2 each of Suraksha Diagnostic Limited (the Company or the Issuer) for cash at a price of Rs. [*] per equity share (including a premium of Rs. [*] per equity share) (the Offer Price) aggregating up to Rs. [*] crores through an offer for sale of up to 19,189,330 equity shares of face value of Rs. 2 each aggregating up to Rs. [*] crores, comprising up to 2,132,148 equity shares of face value of Rs. 2 each aggregating up to Rs. [*] crores by Somnath Chatterjee, up to 2,132,148 equity shares of face value of Rs. 2 each aggregating up to Rs. [*] crores by Ritu Mittal, up to 2,132,148 equity shares of face value of Rs. 2 each aggregating up to Rs. [*] crores by Satish Kumar Verma (whose shares are jointly held with Suman Verma) (together with Somnath Chatterjee and Ritu Mittal, the Promoter Selling Shareholders), up to 10,660,737 equity shares of face value of Rs. 2 each aggregating up to Rs. [*] crores by Orbimed Asia ii Mauritius Limited^ (the Investor Selling Shareholder), up to 799,556 equity shares of face value of Rs. 2 each aggregating up to Rs. [*] crores by Munna Lal Kejriwal, and up to 1,332,593 equity shares of face value of Rs. 2 each aggregating up to Rs. [*] crores by Santosh Kumar Kejriwal (together the Individual Selling Shareholders) (the promoter selling shareholders, the investor selling shareholder and the individual selling shareholders, collectively referred to as the Selling Shareholders, and such equity shares offered by the selling shareholders, the Offered Shares) (the Offer or the Offer for Sale). આ ઑફર કંપનીની પોસ્ટ-ઑફર પેઇડ-અપ ઇક્વિટી શેર કેપિટલના [*]% ની રચના કરશે. ^ ઓર્બિમેડ એશિયા II મૉરિશસ એફડીઆઈ ઇન્વેસ્ટમેન્ટ્સ લિમિટેડ, જે અગાઉના શેરહોલ્ડર, ઓર્બિમેડ એશિયા II મૉરિશસ લિમિટેડમાં એકત્રીકરણને અનુસરીને સર્વાઇવિંગ એન્ટિટી. ઇક્વિટી શેરનું ફેસ વેલ્યૂ ₹2 છે અને ઑફરની કિંમત ઇક્વિટી શેરના ફેસ વેલ્યૂના [*] ગણી છે. પ્રાઇસ બેન્ડ અને ન્યૂનતમ બિડ લૉટ કંપની દ્વારા નિર્ધારિત કરવામાં આવશે.